Brief: Pharnext Updates On Collaboration with Galapagos
09/09/2019 07:52
Sept 9 (Reuters) - PHARNEXT SA PHARN.PA :
* PHARNEXT AND GALAPAGOS SUCCESSFULLY ACHIEVED THEIR
RESEARCH AND
DEVELOPMENT COLLABORATION
* COLLABORATION AIMS TO GENERATE A NEW DRUG DEVELOPMENT
PIPELINE
IN SEVERAL THERAPEUTIC AREAS FOR GALAPAGOS
* COLLABORATION HAS LED TO IDENTIFICATION OF INTERESTING
NOVEL
COMBINATIONS THAT ARE NOW IN ADVANCED PRECLINICAL TESTING
Source text for Eikon: ID:nNDL5LK5mm
Further company coverage: PHARN.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Pharnext SCA
See all newsBrief: Pharnext Progresses On Charcot-Marie-Tooth Disease Study
Brief: Pharnext Reports Topline Results From Pivotal Phase III Clinical Trial Of PXT3003 In Charcot-Marie-Tooth Disease Type 1A
Brief: Pharnext Receives Offer Valuing Its Drug Candidate For Charcotmarie-Tooth Disease At Over Eur 500 Mln
Brief: Pharnext Appoints Dr Gilbert Wagener As Chief Medical Officer
Brief: Pharnext Reports Significant Progress In Search For Pharmaceutical Partners To Finance Its Development